Cumulative data, including meta-analyses, support that a decrease in CSF α-synuclein is observed in PD (Sako et al., 2014) and that a decrease in amyloid β42, tau, and phosphorylated tau level is an indicator of cognitive decline in PD (Hu et al., 2017). The gene discussed is MAPT; the disease is Parkinson disease.